AMZN
Amazon.com, Inc.
AMZN has a slight edge over SHAK overall, supported by lower modeled downside and stronger modeled upside.
SHAK
Shake Shack Inc.
SHAK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SHAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
SHAK's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over SHAK in the historical PE scenario, which offers more potential upside but is not a forecast.
SHAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 71x | $72.68 | — |
| Cheap | 75x | $77.60 | +6.8% |
| Fair | 153x | $158 | +117% |
| Expensive | 505x | $520 | +616% |
Historical ranges are pointers, not guarantees.
SHAK's PE is in its cheap range at 71x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
SHAK Forward outlook
There aren't enough analyst estimates for SHAK to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SHAK on earnings, with more consistent year-over-year improvement.
SHAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.03 | 0% |
| Q2 2026 | $0.94 | +100% |
| Q1 2026 | $0.98 | +238% |
| Q4 2025 | $1.09 | +354% |
| Q3 2025 | $1.03 | +442% |
| Q2 2025 | $0.47 | -27% |
| Q1 2025 | $0.29 | -49% |
| Q4 2024 | $0.24 | -50% |
SHAK earned $1.03 per share over the past year, about the same as the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over SHAK on profitability, with a higher operating margin.
SHAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $423.3M | +15% |
| Q2 2026 | $417.6M | +17% |
| Q1 2026 | $366.7M | +14% |
| Q4 2025 | $400.5M | +22% |
| Q3 2025 | $367.4M | +16% |
| Q2 2025 | $356.5M | +13% |
| Q1 2025 | $320.9M | +10% |
| Q4 2024 | $328.7M | +15% |
SHAK has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | 0 points |
| Q2 2026 | 5% | -1.3 points |
| Q1 2026 | -0.7% | -1.6 points |
| Q4 2025 | 4.7% | +1.6 points |
| Q3 2025 | 5% | +11 points |
| Q2 2025 | 6.3% | +2.9 points |
| Q1 2025 | 0.9% | +0.9 points |
| Q4 2024 | 3.1% | +3.6 points |
SHAK's operating margin was 5.1% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SHAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.1M | -45% |
| Q2 2026 | -$736K | -103% |
| Q1 2026 | -$38.7M | -2170% |
| Q4 2025 | $4M | -62% |
| Q3 2025 | $23.7M | +237% |
| Q2 2025 | $26.9M | +31% |
| Q1 2025 | $1.9M | +$4.3M |
| Q4 2024 | $10.4M | +23% |
SHAK has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SHAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +44K shares |
| 1 year | +0.1% | +36K shares |
| 3 years | -4.7% | -2.1M shares |
| 5 years | +7.1% | +2.8M shares |
| Available history | +30% | +9.7M shares |
SHAK has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SHAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
SHAK has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SHAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 75.5 | Neutral |
SHAK's weekly RSI is 53 (neutral) and its Stochastic is 76 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over SHAK on valuation relative to its sector.
SHAK PE vs Consumer Cyclical Sector
| Metric | SHAK | Sector median | Relative |
|---|---|---|---|
| PE | 71x | 18x | 292% above |
| PE % | 11 | 47 | 36 pts below |
SHAK is trading at 71x earnings, a 292% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over SHAK on trend strength, trading above more of its moving averages.
SHAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.7 | 9% above |
| 20 week MA | $65.3 | 11% above |
| 50 week MA | $75.9 | 4.3% below |
| 100 week MA | $92.0 | 21% below |
| 200 week MA | $86.9 | 16% below |
SHAK has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 16% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over SHAK on returns for 2026, with the stronger performance.
SHAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.5 | $87.8 | +45% |
| 2021 | $87.8 | $74.5 | -15% |
| 2022 | $74.5 | $44.9 | -40% |
| 2023 | $44.9 | $74.1 | +65% |
| 2024 | $74.1 | $132.6 | +79% |
| 2025 | $132.6 | $83.8 | -37% |
| 2026 YTD | $83.8 | $72.7 | -13% |
SHAK has finished lower in three of the last six years. It's down 13% so far in 2026.